MECHANISM OF ACTION
The Meno-Pause blend is a proprietary (not publicly disclosed) combination of peptides grouped around the hormonal signalling axis that changes with age. Based on the known components, it likely includes: a peptide to support the hormonal signalling system (the brain-pituitary-ovary communication chain) that changes with age; a peptide to support mood, calm, and mental clarity during the transition; and a repair-focused peptide for the physical changes like joint aches and tissue changes. Rather than replacing hormones with synthetic oestrogen, the approach tries to use the body's own peptide signalling systems to support balance during the transition. The exact formula and ratios are proprietary to the Peptide Pen brand.
RESEARCH APPLICATIONS
- HPG axis signalling research
- GnRH and LH pulsatility modelling
- Peptide blend comparative research
- Age-related endocrine signalling studies
RESEARCH HIGHLIGHTS
Blend of researched components
Each component has its own body of laboratory research covering the signalling pathway it acts on. See the individual compound pages for that research.
Ref: See individual compound pages
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
2–8°C. Follow standard peptide storage - keep cold, protect from light, use reconstituted solution within 21 days.
Regulatory Status
Unscheduled in South Africa. Supplied for laboratory and research use only. Not a registered medicine, not evaluated by SAHPRA, not for human consumption. Not WADA prohibited.
Important - read before proceeding
This page is a summary of published scientific literature about a molecule. It is provided for research and educational purposes only. Nothing on this page is medical advice, a diagnosis, a recommendation, a prescription, or a claim that this compound treats, cures, prevents or improves any condition in humans. Research findings described here are observations reported by third-party researchers about the molecule - they are not statements about the product supplied by Bio Intelligence, and they should not be read as an expected outcome.
Compounds supplied are not registered medicines, have not been evaluated by SAHPRA, and are not for human consumption. No dosing, route of administration or usage guidance is provided by Bio Intelligence. If you have a health concern, speak to a registered healthcare practitioner.